Par Pacific (PARR) had the highest return between June 28, 2012 and December 10, 2012 by a US stock, returning 1,566.7%.
| ASSET | DATE | % RETURN |
|---|---|---|
Par Pacific (PARR) | 6/28/2012 - 12/10/2012 | 1,566.67% |
Astrana Health (ASTH) | 6/28/2012 - 12/10/2012 | 941.67% |
Sarepta Therapeutics (SRPT) | 6/28/2012 - 12/10/2012 | 552.99% |
Kazia Therapeutics Ltd ADR (KZIA) | 6/28/2012 - 12/10/2012 | 404.45% |
MEI Pharma (MEIP) | 6/28/2012 - 12/10/2012 | 328% |
Paysign (PAYS) | 6/28/2012 - 12/10/2012 | 312.5% |
BioLife Solutions (BLFS) | 6/28/2012 - 12/10/2012 | 300% |
Harrow Health (HROW) | 6/28/2012 - 12/10/2012 | 235% |
Security National Financial (SNFCA) | 6/28/2012 - 12/10/2012 | 234.16% |
Fennec Pharmaceuticals (FENC) | 6/28/2012 - 12/10/2012 | 226.75% |
ZEN Graphene Solutions (ZTEK) | 6/28/2012 - 12/10/2012 | 192.31% |
Consumer Portfolio Services (CPSS) | 6/28/2012 - 12/10/2012 | 185.64% |
POET Technologies (POET) | 6/28/2012 - 12/10/2012 | 185% |
Soligenix (SNGX) | 6/28/2012 - 12/10/2012 | 178% |
Portage Biotech (PRTG) | 6/28/2012 - 12/10/2012 | 166.67% |
CorMedix (CRMD) | 6/28/2012 - 12/10/2012 | 159.61% |
ACADIA Pharmaceuticals (ACAD) | 6/28/2012 - 12/10/2012 | 153.33% |
Imunon (IMNN) | 6/28/2012 - 12/10/2012 | 152.78% |
Milestone Scientific (MLSS) | 6/28/2012 - 12/10/2012 | 152.5% |
Arbutus Biopharma (ABUS) | 6/28/2012 - 12/10/2012 | 151.71% |
Supercom (SPCB) | 6/28/2012 - 12/10/2012 | 150% |
Travere Therapeutics (TVTX) | 6/28/2012 - 12/10/2012 | 147.37% |
Perion Network (PERI) | 6/28/2012 - 12/10/2012 | 131.36% |
Microbot Medical (MBOT) | 6/28/2012 - 12/10/2012 | 122.5% |
Insmed (INSM) | 6/28/2012 - 12/10/2012 | 121.82% |
